Content about Sulfoxides

April 18, 2011
Study: Drug-drug interaction warning letters work

A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.

April 5, 2011
Takeda tries to block Impax's launch of generic Dexilant

Generic drug maker Impax Labs is hoping to become the first to market a version of a gastroesophageal reflux disease treatment made by Takeda Pharmaceutical.

April 5, 2011
Takeda: Dexilant, Prevacid have less inhibiting effects on Plavix's efficacy than counterparts

Studies have indicated that proton-pump inhibitors, used for treating gastroesophageal reflux disease, reduce the efficacy of a popular blood-thinning drug, but Takeda Pharmaceuticals North America announced on Tuesday the results of a new study indicating that its own PPIs may have less of an effect.

April 4, 2011
PL Developments to sell, distribute store-brand generic Zegerid OTC

PL Developments on Monday announced that it has acquired the exclusive rights to sell and distribute store-brand over-the-counter versions of omeprazole sodium bicarbonate capsules, the generic version of Merck’s Zegerid OTC.

March 30, 2011
Valeant seeks to buy Cephalon

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

March 25, 2011
Study: Vimovo 'well-tolerated' among osteoarthritis patients

A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

March 2, 2011
Report: FDA warns of long-term PPI use

The Food and Drug Administration is warning that long-term use of a class of drugs for gastroesophageal reflux disease may decrease levels of magnesium in the body and increase the risk of such side effects as seizures and heart rhythm problems, according to published reports.

February 10, 2011
Actavis OKed to market generic Protonix

Actavis has received approval from the Food and Drug Administration to market a generic version of a popular gastroesophageal reflux disease treatment.

February 2, 2011
Eisai receives complete response letter for GERD treatment

The Food and Drug Administration declined to approve a drug made by Eisai for treating gastroesophageal reflux disease, Eisai said Tuesday.

January 24, 2011
Matrix Labs' generic Protonix DR receives FDA approval

The Food and Drug Administration has approved a treatment for gastroesphageal reflux disease made by a subsidiary of Mylan, the generic drug maker said Monday.

January 21, 2011
Dr. Reddy's receives FDA approval for generic GERD treatment

Indian drug maker Dr. Reddy’s Labs has launched a generic treatment for gastroesophageal reflux disease.

December 22, 2010
Prilosec OTC’s ‘Heartburn gone … power on’ tagline nixed by NAD

The National Advertising Division of the Council of Better Business Bureaus on Tuesday ruled that Procter & Gamble provided reasonable support for claims that Prilosec OTC provides “superior acid control” over a competing product, Prevacid 24HR. However, the NAD recommended P&G discontinue a comparative claim made in a context that doesn’t reference acid control, the review board added.

November 15, 2010
Takeda launches GetToKnowGERD.com

Drug maker Takeda Pharmaceuticals is launching a campaign to raise awareness of gastroesophageal reflux disease,...

October 25, 2010
Prilosec OTC taps two football stars for Living Proof campaign

Procter & Gamble on Tuesday announced the signing of two NFL offensive linemen — New...

October 24, 2010
FDA approves REMS for Nuvigil, Provigil

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

October 18, 2010
Dr. Reddy's to launch generic Prevacid

Dr. Reddy's disclosed on Tuesday it will market a generic peptic ulcer treatment....

October 17, 2010
Teva, Sandoz launch Prevacid SoluTab generics

The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market...

August 12, 2010
FDA's new video addresses fracture risk when using PPIs

The Food and Drug Administration on Aug. 9 posted a video outlining the revised prescription...

July 18, 2010
Nycomed's Protonix patent upheld

A U.S. District Court has ruled in favor of two companies who alleged patent infringement...

June 14, 2010
Intellipharmaceutics files new drug application for generic Protonix

Intellipharmaceutics has filed an abbreviated new drug application for a generic drug designed to treat...

June 6, 2010
Marketing pieces of the digestive puzzle

When Schering-Plough Consumer Healthcare began distributing its Zegerid OTC in April, the last piece of...

May 24, 2010
FDA: Prolonged PPI use may increase risk of bone fractures

Prolonged use of a common class of drugs for treating digestive problems may increase the...

May 2, 2010
FDA approves Vimovo

The Food and Drug Administration has approved a drug by AstraZeneca and Pozen for treating...

March 29, 2010
FTC wins pay-for-delay battle

The Federal Trade Commission’s crusade against patent settlements between branded and generic drug makers moved...

March 29, 2010
Jet lag treatment receives complete response letter

The Food and Drug Administration declined to approve a Cephalon drug as a treatment for...

© 2013 Drug Store News. All Rights Reserved.